Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 210 participants.

Also called NCT04088292

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04088292
Other papers using this trial's data
  • Randomized trial of low-dose, ultrasound-assisted thrombolysis or heparin for pulmonary embolism Cardiovascular research, 2026-03-26 DOI, PubMed 41610160

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04088292. Randomized; single masking; primary purpose treatment. Start 2019-06-06 (actual); primary completion 2024-06-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
Acronym
STRATIFY
Intervention (Drug)
Alteplase 20 Mg Powder for Solution for Injection Vial
Intervention (Device)
Ultrasound assisted Thrombolysis
Lead sponsor
Copenhagen University Hospital, Rigshospitalet (class: other)
Collaborator
Herlev and Gentofte Hospital (class: other)
Collaborator
University Hospital Bispebjerg and Frederiksberg (class: other)
Collaborator
Hillerod Hospital, Denmark (class: other)
Collaborator
Copenhagen University Hospital, Hvidovre (class: other)

Record details

Record id
cardio:ct-nct04088292
Content hash
8eaf57b75cfffaed65e288d06627886e0f0b398354113717be0a6adc61dd54fb